Clinical trial Recruiting at 1 site Interventional Ages 65 to 80

Understanding muscle power and control to prevent falls in knee osteoarthritis patients

Official title: Analisi Della Perdita di Forza e Potenza Muscolare e Del Degrado Del Controllo Motorio Per la Predizione Delle Cadute in Una Popolazione Affetta da Artrosi di Ginocchio

Run by Istituto Ortopedico Rizzoli · NCT06611618 · Data updated 2026-11-12

This study is trying to see if measuring muscle power and control can better predict fall risks in older adults with knee osteoarthritis than just looking at muscle strength alone.

More Knee Osteoarthritis (Knee OA) trials

Quick facts

Study typeInterventional
Ages65 Years to 80 Years
SexAll
Enrollment50 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedJanuary 30, 2025
Main results expectedDecember 31, 2028
Study endsJune 30, 2029
Registry record updatedNovember 9, 2026
Trial IDNCT06611618 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly individuals aged 65 to 80 with knee osteoarthritis and no history of falls in the past year.

Probably not a fit

Patients with significant comorbidities or conditions that affect muscle function or MRI compatibility may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the relationship between muscle power, strength, and motor control degradation in predicting fall risks among elderly patients with knee osteoarthritis. Participants will undergo various assessments, including muscle force and power evaluations using a dynamometer, home-based mobility monitoring, and MRI scans of the lower limbs. The goal is to determine if muscle power and motor control are more effective predictors of falls than muscle strength alone. Data will be collected over 24 months through multiple visits to monitor changes and inform strategies for fall prevention.

Why it matters

Potential benefit: If successful, this study could lead to improved fall prevention strategies for elderly patients with knee osteoarthritis.

How similar studies have gone: While the approach of assessing muscle power and control in relation to fall risk is innovative, similar studies have shown promise in understanding fall risks in elderly populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 65 and 80 years
* Kellgren score II e III
* No history of falls in the last 12 months

Exclusion Criteria:

* Any musculoskeletal, neurological, rheumatic or tumoral diseases
* Dementia
* Diabetes
* Inguinal or abdominal hernia
* Severe Hypertension (Level 3)
* Severe Cardio-pulmonary insufficiency
* Diagnosis of Osteonecrosis in the lower limb joints
* Pathologies or physical conditions incompatible with the use of magnetic resonance imaging and electrostimulation (i.e., active and passive implanted biomedical devices, epilepsy, severe venous insufficiency in the lower limbs)
* Previous interventions or traumas to the joints of the lower limb

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Lisa Berti, Professor — IRCCS Istituto Ortopedico Rizzoli
  • Study coordinator: Lisa Berti, Professor
  • Email: lisa.berti@ior.it
  • Phone: +390516366529

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.